These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged? Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123 [TBL] [Abstract][Full Text] [Related]
3. Survival of heparins, oral anticoagulants, and aspirin after the year 2010. Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143 [TBL] [Abstract][Full Text] [Related]
4. Prevention and management of venous thromboembolism in pregnancy. James AH Am J Med; 2007 Oct; 120(10 Suppl 2):S26-34. PubMed ID: 17916457 [TBL] [Abstract][Full Text] [Related]
5. [Thrombolytic treatment in pregnancy and during labor]. Brandt M; Niedner W Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(3):477-82. PubMed ID: 63436 [No Abstract] [Full Text] [Related]
7. Current trends in antithrombotic drug and device development. Fareed J Semin Thromb Hemost; 1996; 22 Suppl 1():3-8. PubMed ID: 8807721 [TBL] [Abstract][Full Text] [Related]
8. The future of anticoagulation. Hoppensteadt DA; Jeske W; Walenga J; Fareed J Semin Respir Crit Care Med; 2008 Feb; 29(1):90-9. PubMed ID: 18302091 [TBL] [Abstract][Full Text] [Related]
9. Assessment and management of high-risk pregnancies in women with thrombophilia. Sarig G; Vidergor G; Brenner B Blood Rev; 2009 Jul; 23(4):143-7. PubMed ID: 19135285 [TBL] [Abstract][Full Text] [Related]
11. Hemostasis and thrombosis in critically ill children. Kenet G; Strauss T; Kaplinsky C; Paret G Semin Thromb Hemost; 2008 Jul; 34(5):451-8. PubMed ID: 18956285 [TBL] [Abstract][Full Text] [Related]
12. Acquired thrombophilia in pregnancy: essential thrombocythemia. Griesshammer M; Grünewald M; Michiels JJ Semin Thromb Hemost; 2003 Apr; 29(2):205-12. PubMed ID: 12709924 [TBL] [Abstract][Full Text] [Related]
13. The use of unfractionated heparin and low molecular weight heparins in pregnancy. Casele HL Clin Obstet Gynecol; 2006 Dec; 49(4):895-905. PubMed ID: 17082684 [TBL] [Abstract][Full Text] [Related]
14. Management of thromboembolism in pregnancy. Marks PW Semin Perinatol; 2007 Aug; 31(4):227-31. PubMed ID: 17825678 [TBL] [Abstract][Full Text] [Related]
15. Cerebral venous congestion as indication for thrombolytic treatment. Tsai FY; Kostanian V; Rivera M; Lee KW; Chen CC; Nguyen TH Cardiovasc Intervent Radiol; 2007; 30(4):675-87. PubMed ID: 17573553 [TBL] [Abstract][Full Text] [Related]
16. [Anticoagulant therapy in patients with heart valve prostheses. Considerations on teratogenesis and anesthesia]. Chiefari M; Brita G; Sbordone L; Pizzicato B Arch Ostet Ginecol; 1980; 85(5):433-9. PubMed ID: 7344676 [No Abstract] [Full Text] [Related]
17. The hypercoagulable state. Who, how, and when to test and treat. Brigden ML Postgrad Med; 1997 May; 101(5):249-52, 254-6, 259-62 passim. PubMed ID: 9158617 [TBL] [Abstract][Full Text] [Related]
18. The management of thrombosis in pregnancy: role of low-molecular-weight heparin. Kher A; Bauersachs R; Nielsen JD Thromb Haemost; 2007 Apr; 97(4):505-13. PubMed ID: 17393011 [TBL] [Abstract][Full Text] [Related]
19. Laboratory tests for the diagnosis of thrombotic disorders. Miller CH Clin Obstet Gynecol; 2006 Dec; 49(4):844-9. PubMed ID: 17082679 [TBL] [Abstract][Full Text] [Related]